Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.73 -0.37 (-0.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Operating Margin (2021 - 2026)

Updated

Kiniksa Pharmaceuticals International (KNSA) recorded Operating Margin of 11.16% in Q2 2026, down 1.69 percentage points from 12.86% a year earlier and down 2.50 percentage points from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Operating Margin (2021 - 2026) Analysis & Trends

On a TTM basis, Kiniksa Pharmaceuticals International's Operating Margin came in at 11.92% as of Jun 30, 2026, up 11.08 percentage points year-over-year; for FY2025, it came in at 11.40%, up 22.17 percentage points from FY2024.

  • Annual Operating Margin has a four-year change of +417.78 percentage points (FY2021 to FY2025).
  • Across earlier years, Operating Margin came in at -10.78% in FY2024 (-1.45 pp), -9.32% in FY2023 (-13.76 pp), 4.44% in FY2022 (+410.82 pp) and -406.38% in FY2021.
  • Quarterly Operating Margin has ranged from -253.55% in Q3 2021 to 46.82% in Q3 2022 over the past five years.
  • On a year-over-year basis, Operating Margin rose in six of the last eight quarters, with an average year-over-year change of +10.61 percentage points.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 454.61 percentage points in Q2 2022, against a drop of 63.12 percentage points in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at 13.66% (Q1 2026), 9.78% (Q4 2025) and 13.28% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Kiniksa Pharmaceuticals International 11.87 Bn 10.61 Bn 220.03 Mn 11.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.16%
Mar 31, 2026 13.66%
Dec 31, 2025 9.78%
Sep 30, 2025 13.28%
Jun 30, 2025 12.86%
Mar 31, 2025 9.63%
Dec 31, 2024 -15.75%
Sep 30, 2024 -8.61%
Jun 30, 2024 -0.11%
Mar 31, 2024 -20.71%
Dec 31, 2023 0.10%
Sep 30, 2023 -16.30%
Jun 30, 2023 -4.41%
Mar 31, 2023 -23.16%
Dec 31, 2022 9.77%
Sep 30, 2022 46.82%
Jun 30, 2022 -71.81%
Mar 31, 2022 -72.44%
Dec 31, 2021 -192.75%
Sep 30, 2021 -253.55%
API Access

Kiniksa Pharmaceuticals International Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=KNSA&period=max&api_key=YOUR_API_KEY